Non-melanoma Skin Cancers in Patients on Hydroxyurea for Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Systematic Review

Hydroxyurea (HU) or hydroxycarbamide is a cytotoxic antimetabolite widely used to treat Philadelphia chromosome-negative Myeloproliferative Neoplasms (Ph-MPN) like Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Primary Myelofibrosis (PMF). Patients with Ph-MPN are at an increased risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavini, Divya R, Salvi, Dhairya J, Shah, Prutha H, Uma, Davuluri, Lee, Jun Hee, Hamid, Pousette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420994/
https://www.ncbi.nlm.nih.gov/pubmed/34527458
http://dx.doi.org/10.7759/cureus.16978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420994/
https://www.ncbi.nlm.nih.gov/pubmed/34527458
http://dx.doi.org/10.7759/cureus.16978

Ejemplares similares